Dec 21, 2025 04:00AM
Nov 12, 2025 10:00AM
Nov 6, 2025 04:30PM
Aug 7, 2025 04:30PM
Jul 22, 2025 08:02AM
Jul 22, 2025 08:00AM
Mar 15, 2025 06:40PM Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRĪ±ME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
Dec 10, 2024 08:00AM
Nov 13, 2024 04:30PM
Nov 1, 2024 08:00AM
Sep 14, 2024 03:00AM
Aug 22, 2024 08:04AM
Aug 22, 2024 08:00AM
May 13, 2024 04:30PM Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
Apr 30, 2024 08:00AM
Jan 4, 2024 04:05PM
Dec 14, 2023 04:05PM
Dec 11, 2023 04:05PM
Dec 11, 2023 04:05PM
Nov 13, 2023 04:30PM
May 15, 2023 08:00AM Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
Mar 30, 2023 04:30PM
Jan 9, 2023 04:05PM
Jan 9, 2023 04:05PM
Dec 10, 2022 10:30AM
Nov 8, 2022 04:30PM
Aug 8, 2022 04:30PM
Jun 28, 2022 09:11AM Pre-Open Stock Movers 06/28: Spirit Gains on Revised Bid; Nike Falls Following Results (more...)
Jun 3, 2022 04:01PM
Jun 2, 2022 07:00AM
May 9, 2022 04:30PM
Apr 29, 2022 05:00PM
Apr 8, 2022 01:00PM
Apr 5, 2022 07:00AM
Mar 30, 2022 04:05PM Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-Drug Conjugate Modality at the 12th Annual World ADC
Mar 3, 2022 07:00AM
Feb 28, 2022 04:35PM
Jan 6, 2022 07:00AM
Jan 5, 2022 04:32PM
Jan 5, 2022 04:30PM
Dec 27, 2021 07:02AM
Dec 27, 2021 07:00AM Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion Data for Antibody-Drug Conjugate Program STRO-002 for Treatment of Advanced Ovarian Cancer
Dec 27, 2021 07:00AM
Dec 13, 2021 07:00AM
Nov 22, 2021 07:00AM
Nov 17, 2021 07:02AM
Nov 17, 2021 07:00AM
Nov 10, 2021 07:00AM
Nov 2, 2021 07:00AM Sutro Biopharma to Participate in Three Upcoming Investor Conferences
Oct 12, 2021 07:02AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All